home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

301 rows where filing_period = "third_quarter", filing_year = 2023 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

issue_code 1

  • MED · 301 ✖

filing_year 1

  • 2023 · 301 ✖

filing_period 1

  • third_quarter · 301 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3043460 HEALTHCARE LEGAL RESOURCES NETWORK, LLC 09c7ae28-d125-4ba1-ac1e-dea8c8dc787e Q3 HEALTHCARE LEGAL RESOURCES NETWORK, LLC 401107302 HEALTHCARE LEGAL RESOURCES NETWORK, LLC 2023 third_quarter MED Pharmaceutical Federal Aviation Administration (FAA),Homeland Security, Dept of (DHS),SENATE     0 0 2023-09-23T12:23:45-04:00
3043707 AUBURN HEALTH STRATEGIES, LLC 4a3c7cef-16e2-4440-a93d-026d5b56d41f Q3 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2023 third_quarter MED proficiency testing for clinical laboratories Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-09-29T16:17:38-04:00
3043778 OCAL LOBBYING GROUP ddb52511-1e7a-4a1d-8141-22e375f80d9f Q3 OCAL LOBBYING GROUP 401106825 SAMERA S.A. 2023 third_quarter MED Obtain funding for Tuberculosis monitoring. Natl Institutes of Health (NIH)     0 0 2023-10-01T09:55:40-04:00
3043804 MARSHALL BRACHMAN f7e9f0c1-7544-4948-8c61-1b181209a8ca Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2023 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2023-10-01T10:38:04-04:00
3043826 FRANCIS EDWARD & CRONIN, INC. 059efb88-c915-4c8c-828a-702cfc21cf0a Q3 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2023 third_quarter MED Legislation related to Alzheimer's disease research Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2023-10-01T12:23:07-04:00
3043827 FRANCIS EDWARD & CRONIN, INC. cdfcb3c0-49b2-4e60-a7e1-94280031694f Q3 FRANCIS EDWARD & CRONIN, INC. 311314 USAGAINSTALZHEIMER'S 2023 third_quarter MED Legislation related to the treatment, detection, and prevention of Alzheimer's disease Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-10-01T12:28:05-04:00
3043857 RAY C CULVER III 8d7e22ff-e812-4815-8db5-397e30a65ae0 Q3 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2023 third_quarter MED Funding for USDA ARS human nutrition research funding in the House (H.R. 4368) and Senate (S. 2131) FY24 appropriations bills. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-10-01T18:48:56-04:00
3043968 HELIX, INC. fae55b4d-c123-4c40-86d6-d1acc71dbf10 Q3 HELIX, INC. 401106164 HELIX, INC. 2023 third_quarter MED US S 2640 Disease X Act 2023, viral surveillance in general sequencing as it relates to discovery of Disease X, development of medical counter-measures Oversight of Lab Developed Tests, express legislative authority Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2023-10-02T11:10:56-04:00
3043996 THE PETRIZZO GROUP, INC. be7fe919-b3dd-4915-9569-067d1e3ea2ff Q3 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2023 third_quarter MED Increased funding for pediatric medical research HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-10-02T12:04:48-04:00
3044008 THE PETRIZZO GROUP, INC. 8ad9d605-47e0-455c-b4aa-35a82f682cf0 Q3 THE PETRIZZO GROUP, INC. 305932 DYSAUTONOMIA INTERNATIONAL 2023 third_quarter MED Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 45000   0 0 2023-10-02T12:10:09-04:00
3044011 THE PETRIZZO GROUP, INC. 57195bf8-bf56-4ebd-bb3e-b4e4b5d75317 Q3 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2023 third_quarter MED Development and execution of advocacy initiatives involving multi Omeros pipeline targets before the U.S. Government. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 75000   0 0 2023-10-02T12:15:25-04:00
3044067 LOBBYIT.COM d8a4ef1d-8dd2-44b1-a78f-a311e54386a2 Q3 LOBBYIT.COM 400487397 BRAIN ANEURYSM FOUNDATION 2023 third_quarter MED Advocate for the passage of Ellie's Law (H.R. 902, S. 895) Creation of a dedicated Brain Aneurysm Caucus Appropriation Requests HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-10-02T13:11:53-04:00
3044604 THE HARRIS FIRM f9132d34-e805-44aa-a9ab-f5de104c6b9d Q3 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2023 third_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-10-03T22:06:58-04:00
3044661 2359 STRATEGIES 176c568f-4c61-4d23-a80e-fa1a6ed97aec Q3 2359 STRATEGIES 401106114 TRAVERE THERAPEUTICS 2023 third_quarter MED Rare kidney disease HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2023-10-04T10:43:57-04:00
3044690 WATKINS & EAGER PLLC 3faf52f0-e8d3-4f12-9c15-07aba14a7b68 Q3 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2023 third_quarter MED Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-10-04T11:10:40-04:00
3044789 AMERICAN COLLEGE OF CLINICAL PHARMACY 82c25e29-3255-4516-9a33-602545b2ebf9 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2023 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2023-10-04T14:08:32-04:00
3045008 PENN AVENUE PARTNERS 9e6f454e-f98a-4bce-a71d-855155a4db85 Q3 PENN AVENUE PARTNERS 400918672 CLIFFSIDE LABS, LLC 2023 third_quarter MED Policy and regulatory matters related to the clinical laboratory industry. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-10-04T20:36:32-04:00
3045068 MAGILL ASSOCIATES, LLC 6d6843ab-cc3d-487c-9fd3-dcf74ec4ba91 Q3 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2023 third_quarter MED FY 2024 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-10-05T10:24:30-04:00
3045462 OLD NORTH STRATEGIES, LLC 6249904e-9586-452c-8259-dd4a69f1bfc9 Q3 OLD NORTH STRATEGIES, LLC 401106174 EXELA PHARMA SCIENCES, LLC 2023 third_quarter MED supply chain & FDA issues HOUSE OF REPRESENTATIVES,SENATE 78000   0 0 2023-10-06T10:52:33-04:00
3045695 REPUBLIC CONSULTING, LLC 01c099c1-1135-4f1c-9d07-87e8519d351e Q3 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2023 third_quarter MED Monitor Health Data Policy. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-10-06T15:13:20-04:00
3045733 FEDERAL SOLUTIONS, LLC 08ea7cbd-65e5-414c-bc3e-a56421d74cd0 Q3 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2023 third_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-10-06T16:07:41-04:00
3046354 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 71dfa007-514d-4ff6-9c84-4d6ff303baf6 Q3 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 18411 F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES 2023 third_quarter MED H.R. 2369 The Verifying Accurate Leading-edge IVCT Development Act, Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act, H.R. 3795 The Diagnostics Testing Preparedness Plan Act, H.R. 3631 The State Stockpile Act. (HCR) H. R. 1305 Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2023", and issues related to influenzas preparedness Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA) HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2023-10-09T14:02:54-04:00
3046922 SQUIRE PATTON BOGGS d6abe922-26a3-47db-8c29-3982f0fd24a2 Q3 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2023 third_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-10-10T14:45:09-04:00
3047378 SQUIRE PATTON BOGGS 56958698-46bc-4289-9bfb-ed21b3901612 Q3 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2023 third_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2023-10-11T12:19:46-04:00
3047607 MARSHFIELD CLINIC HEALTH SYSTEM fcd47a96-cef1-4693-a253-5386b750f433 Q3 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2023 third_quarter MED research support, agriculture, farm safety, child care and agriculture communities HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2023-10-11T15:41:18-04:00
3047936 COVINGTON & BURLING LLP 167c3576-99c6-43fc-84db-800502fffdab 3T COVINGTON & BURLING LLP 11195 SL 2T, LLC ("SMARTLABS") 2023 third_quarter MED Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including the House and Senate Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPA) Re-authorization and the Senate National Defense Authorization Act. HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2023-10-12T10:06:40-04:00
3048088 TENAGRITY SOLUTIONS, LLC 814aa5db-4034-4968-9ec7-e49704445b11 Q3 TENAGRITY SOLUTIONS, LLC 401107856 1DAY SOONER 2023 third_quarter MED S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA). Assistance with a letter of support to HHS, encouraging the establishment of an emerging pathogen preparedness program through the FDA. To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-10-12T12:00:51-04:00
3048210 IMPACT MANAGEMENT GROUP 70c18657-2df0-46b2-b2ac-02b60ff34f75 Q3 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2023 third_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-12T13:41:43-04:00
3048218 IMPACT MANAGEMENT GROUP c00c1152-8d6b-4f18-8e82-dad813fbc1be Q3 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2023 third_quarter MED Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 HOUSE OF REPRESENTATIVES     0 0 2023-10-12T13:45:03-04:00
3048326 BEN BARNES GROUP LP 65df41ee-8f86-4dfa-a182-259aedc1b473 Q3 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2023 third_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2023-10-12T15:07:45-04:00
3048347 BEN BARNES GROUP LP 3e7c88bd-7f53-43f9-9856-c373edd9f574 Q3 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2023 third_quarter MED Medical/Disease Research SENATE 11500   0 0 2023-10-12T15:18:55-04:00
3048868 TIBER CREEK GROUP f3ac76c8-f393-49b1-8ae6-3242735382a9 Q3 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2023 third_quarter MED Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-10-13T10:52:44-04:00
3048907 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER b2a10fc0-ecf7-4693-8976-8d96b03a45cc Q3 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2023 third_quarter MED NIH funding, PACT Act, Accelerating Kids Access Act, NIH reform Senate HELP Minority RFI Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   36400 0 0 2023-10-13T11:09:16-04:00
3049138 SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS 7ace6d6d-4431-49a0-ad53-122c67f27a1f Q3 SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS 400570715 SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS 2023 third_quarter MED N/A Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   36000 0 0 2023-10-13T13:48:32-04:00
3049206 THE DLM GROUP 2147c6c6-dc2b-4706-95ec-dc85f2d9b140 Q3 THE DLM GROUP 313794 GENESIS HEALTH CARE, INC. 2023 third_quarter MED no activity HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-10-13T14:20:29-04:00
3049234 THE LIVINGSTON GROUP, LLC 917b8681-9dad-4370-97ff-3c01631f2ad4 Q3 THE LIVINGSTON GROUP, LLC 49635 INNOVATIVE VACCINE TECHNOLOGIES 2023 third_quarter MED FY2024 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-10-13T14:26:43-04:00
3049303 AMERICAN SOCIETY OF ADDICTION MEDICINE 71edb42e-b4b2-46b8-875b-7e7b4060cf49 Q3 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2023 third_quarter MED Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Advocated for certain annual increases for Medicare office based SUD bundled codes. ASAM signed a letter in support of S. 1378, Connecting Our Me… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   40000 0 0 2023-10-13T14:52:06-04:00
3049398 BOLD STRATEGIES, LLC 0856991f-1b7a-48aa-8399-d0aa12978028 Q3 BOLD STRATEGIES, LLC 401104653 PENNINGTON BIOMEDICAL RESEARCH CENTER 2023 third_quarter MED Obesity and COVID research. Appropriations. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-10-13T15:41:20-04:00
3049880 COMMONWEALTH STRATEGIC PARTNERS, LLC 6e657113-4ee3-4321-8b82-90304bcf7c17 Q3 COMMONWEALTH STRATEGIC PARTNERS, LLC 401103486 PEOPLE FOR THE ETHICAL TREATMENT OF ANIMALS (PETA) 2023 third_quarter MED Issues related to animal testing and experimentation HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-10-14T15:46:55-04:00
3049884 COMMONWEALTH STRATEGIC PARTNERS, LLC b6e9e646-0ebe-4b08-b278-3c2c8db50c5f Q3 COMMONWEALTH STRATEGIC PARTNERS, LLC 401103486 AMERICAN ASSOCIATION OF SUICIDOLOGY 2023 third_quarter MED Support policies and research for suicide awareness, training, outreach, and prevention, including but not limited to robust HHS funding and improvements to the 988 program HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-10-14T15:47:59-04:00
3050038 CORNERSTONE GOVERNMENT AFFAIRS, INC. 0414035f-9213-46f2-9480-484e867f9ef4 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE UNIVERSITY OF TEXAS SYSTEM 2023 third_quarter MED Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-10-14T23:13:58-04:00
3050057 TRUSYNERGY 062a2723-3ee1-4031-b53e-f597caed6546 Q3 TRUSYNERGY 401107715 BURRELL INTERNATIONAL GROUP (ON BEHALF OF ARSENAL MEDICAL, INC.) 2023 third_quarter MED Funding for medical devices for hemorrhages; provisions in FY24 NDAA and FY24 Defense Appropriations HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-10-15T11:50:40-04:00
3050130 POWERS PYLES SUTTER & VERVILLE, P.C. f4b8d11e-f0d8-45bb-a4d2-3614ea9680af Q3 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 MOSES WEITZMAN HEALTH SYSTEM, INC. 2023 third_quarter MED FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills S.2840, Bipartisan Primary Care and Health Workforce Act FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Authorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Training Programs, Postgraduate Psychiatric Fellowships, Medical Assistant Training Programs, and other Health Workforce Training Programs House, Senate Legislation to Fund Education, Training and Technical Assistance in Support of the National Health Workforce House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs and Providers House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Health Centers, Rural Health Clinics, and Elsewhere House, Senate Infrastructure Bills Administration for Children & Families (ACF),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Employment & Training Administration,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Veterans Affairs, Dept of (VA),Veterans Employment & Training Service 10000   0 0 2023-10-15T13:59:40-04:00
3050160 POWERS PYLES SUTTER & VERVILLE, P.C. 942cd082-40a6-4370-83ec-4b04781b9481 Q3 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 PIH HEALTH FOUNDATION 2023 third_quarter MED FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations(E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 30000   0 0 2023-10-15T15:26:26-04:00
3050239 POWERS PYLES SUTTER & VERVILLE, P.C. 41818304-8413-4079-a02a-73cf71bd8f84 Q3 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 CORNERSTONE CARE, INC. 2023 third_quarter MED FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of     0 0 2023-10-15T16:33:04-04:00
3050305 CORNERSTONE GOVERNMENT AFFAIRS, INC. feace693-322c-439b-97ad-74baf650c70e Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PULMONARY FIBROSIS FOUNDATION 2023 third_quarter MED Appropriations for research on pulmonary fibrosis HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-10-15T21:54:55-04:00
3050313 CORNERSTONE GOVERNMENT AFFAIRS, INC. fd47fa1f-b6e4-47bf-828f-913bbd75b2c1 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 2023 third_quarter MED Discussions regarding patient access to radiation oncology. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 50000   0 0 2023-10-15T22:52:18-04:00
3050338 CORNERSTONE GOVERNMENT AFFAIRS, INC. 713c5ef7-1ade-428d-bd4c-0b72bea0e0cb Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 JOHNS HOPKINS UNIVERSITY 2023 third_quarter MED Advised on fiscal year 2024 appropriations; Medicare reimbursement; Graduate Medical Education; Childrens hospital Graduate Medical Education; higher education; price transparency; telehealth; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; and clinical trial legislative and regulatory issues. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2023-10-15T23:53:59-04:00
3050373 CORNERSTONE GOVERNMENT AFFAIRS, INC. f328460c-e832-4e9b-b8f7-ae1ab502e94e Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 OU MEDICINE, INC. 2023 third_quarter MED Research and development of medical programs in partnership with Department of Health and Human Services and other federal agencies Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-10-16T00:33:04-04:00
3050606 UNIVERSITY OF IOWA 2b7dba95-e15e-4572-9848-52fca1321b09 Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2023 third_quarter MED N.A. HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2023-10-16T10:24:44-04:00
3050759 VENABLE LLP 5bf23ec1-9887-4aa6-86f4-aff57a2c1018 Q3 VENABLE LLP 39941 SPINA BIFIDA ASSOCIATION 2023 third_quarter MED Spina Bifida Awareness Month HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-10-16T11:07:15-04:00
3051058 THE CONSILIO GROUP c642f148-7ad4-4aa6-bf37-68a2f0f4a71d Q3 THE CONSILIO GROUP 400374717 DETECTACHEM 2023 third_quarter MED Colorimetric explosive and narcotic detection capabilities Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2023-10-16T12:38:13-04:00
3051236 IPOLICY SOLUTIONS 71d5d584-2702-4a81-a534-93e5c62c2ed2 Q3 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2023 third_quarter MED No bill #: Verified Innovative Testing in American Laboratories Act H.R.2369 - VALID Act of 2023 FDA Proposed Rulemaking on LDTs HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 45000   0 0 2023-10-16T14:07:35-04:00
3051244 IPOLICY SOLUTIONS 9469d6c4-1c06-4d99-b800-f23fdcf9bc1a Q3 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2023 third_quarter MED H.R.2369 - VALID Act of 2023 FDA RFI: Increasing Patient Access to At-Home Use Medical Technologies Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-10-16T14:12:52-04:00
3051283 THE JACKSON LABORATORY 48d70e2f-f057-4ba6-88c2-721d95f8ee92 Q3 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2023 third_quarter MED Issues related to biomedical research. Animal model use in biomedical research. HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE   30000 0 0 2023-10-16T14:23:12-04:00
3051329 EMERGENT STRATEGIES 080a7cbf-94c6-40b7-bff5-f303e6408e93 Q3 EMERGENT STRATEGIES 401104778 ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2023 third_quarter MED Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2023-10-16T14:48:05-04:00
3051359 MCDERMOTT+ LLC 3893d6d4-493a-45fe-b262-5614d152aef0 Q3 MCDERMOTT+ LLC 401103287 VERILY LIFE SCIENCES LLC 2023 third_quarter MED Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-16T14:54:49-04:00
3051370 PETER DAMON GROUP LLC c0403949-3b4d-4368-b5c1-c2347f53d641 Q3 PETER DAMON GROUP LLC 401104738 OLD NORTH STRATEGIES, LLC ON BEHALF OF EXELA PHARMA SCIENCES, LLC 2023 third_quarter MED Supply chain & FDA issues HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2023-10-16T14:57:39-04:00
3051423 MICHAEL N. MCCARTY LAW OFFICE PLLC e49dad4e-1f7b-46ba-82df-5a13cfdabc92 Q3 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2023 third_quarter MED Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical laboratory test results; support funding for CDC's Environmental Health Laboratory to establish pediatric reference intervals for diagnostic laboratory tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed in vitro diagnostic tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration; funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-10-16T15:25:43-04:00
3051491 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) cbe61bd7-acaa-4d6e-96d7-05facde9ead9 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2023 third_quarter MED AACC/ADLM wrote and met with the Office of Management and Budget to raise concerns about advancing a proposed rule [Docket No. FDA-2023-N-2177], which would extend the authority of the Food and Drug Administration to regulate laboratory developed tests. Office of Management & Budget (OMB)   70000 0 0 2023-10-16T15:49:13-04:00
3051570 POWERS PYLES SUTTER & VERVILLE, P.C. 47d49df8-d346-4907-9e54-db1b1864b380 Q3 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 HERBERT J. THOMAS MEMORIAL HOSPITAL ASSOCIATION (FKA THOMAS HEALTH) 2023 third_quarter MED Consolidated Appropriations Act, FY 2022, H.R. 2741, now P.L. 117-103 (FY 2022 CDS Implementation) FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care, Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine/Telehealth in Hospitals House, Senate Infrastructure Bills Administration for Children & Families (ACF),Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of 90000   0 0 2023-10-16T16:09:55-04:00
3051768 POWERS PYLES SUTTER & VERVILLE, P.C. 2eddff36-bb36-4044-999c-f3d6b777029e Q3 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION 2023 third_quarter MED FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Care Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 20000   0 0 2023-10-16T17:05:59-04:00
3051924 TIDES GROUP, LLC 78f804d1-341b-46f0-99a6-1a1b80dc4dd7 3A TIDES GROUP, LLC 401105835 AGENUS INC. 2023 third_quarter MED Issues related to colorectal cancer immunotherapy. HOUSE OF REPRESENTATIVES 30000   0 0 2023-10-16T18:09:06-04:00
3052043 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 7a2ab46f-9b2c-47a0-8a4a-5e26e1e305ea Q3 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2023 third_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-10-16T19:55:12-04:00
3052135 CORNERSTONE GOVERNMENT AFFAIRS, INC. 214421c1-5d2a-4897-853a-06108504d69d Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 GINKGO BIOWORKS, INC. 2023 third_quarter MED Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, biomanufacturing, and critical minerals. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-10-16T23:56:08-04:00
3052137 CORNERSTONE GOVERNMENT AFFAIRS, INC. 72cd4b5d-9c5e-4e6f-85e4-4c502f8ae609 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MATERIALS AND DEVICES, INC. 2023 third_quarter MED Educated key government stakeholders on AMADs products applicable to the military. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-10-16T23:58:11-04:00
3052141 CORNERSTONE GOVERNMENT AFFAIRS, INC. f11b7cec-8c1a-4573-8666-f61da2e598fc Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 NIRSENSE, LLC (FKA BIONICA LABS) 2023 third_quarter MED Educated key government stakeholders on Bionicas activities and technologies in support of the Armed Forces. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-10-17T00:00:51-04:00
3052148 CORNERSTONE GOVERNMENT AFFAIRS, INC. f6866622-11d4-423a-819c-17dd8fe09dcc Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM 2023 third_quarter MED Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-17T00:06:06-04:00
3052153 CORNERSTONE GOVERNMENT AFFAIRS, INC. 0e441954-e0c6-4ad8-9725-3ad5aa9f2397 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 SCIPERIO INC. 2023 third_quarter MED Educated key government stakeholders on Sciperio, Inc.s technology and manufacturing capabilities in support of the Department of Defense. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-17T00:08:53-04:00
3052155 CORNERSTONE GOVERNMENT AFFAIRS, INC. 49127aea-7743-4bfa-8e74-e277b75cbd9c Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 SMITH & NEPHEW 2023 third_quarter MED Educated key government stakeholders on Smith+Nephew products applicable to the military. HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-17T00:11:59-04:00
3052159 CORNERSTONE GOVERNMENT AFFAIRS, INC. 054fe788-006d-4b9b-98a2-77e77ab88abe Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE GENEVA FOUNDATION 2023 third_quarter MED Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-10-17T00:15:29-04:00
3052161 CORNERSTONE GOVERNMENT AFFAIRS, INC. 7c99d4bc-29d7-4b73-9f7e-678899f0cded Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ 2023 third_quarter MED Educated key government stakeholders on the University of Colorados medical capabilities in areas applicable to military health and readiness. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-10-17T00:17:30-04:00
3052166 CORNERSTONE GOVERNMENT AFFAIRS, INC. 07c8306c-1f70-481a-925e-c058580297d5 Q3 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 VOCXI HEALTH 2023 third_quarter MED Educated key government stakeholders on Vocxi Healths technology in support US Service members health and readiness. HOUSE OF REPRESENTATIVES 30000   0 0 2023-10-17T00:29:26-04:00
3052303 EFB ADVOCACY, LLC a2c51ba1-c17f-435d-8d16-b41638086056 Q3 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2023 third_quarter MED Funding Issues related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-10-17T10:08:51-04:00
3052318 DQB INTERNATIONAL 1f3d73a5-34cf-4b43-b8ed-6595dcfedf61 Q3 DQB INTERNATIONAL 291834 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2023 third_quarter MED FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-17T10:13:29-04:00
3052380 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 4aafdb8e-39e6-4f50-9161-ca675e0e59de Q3 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 401104196 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 2023 third_quarter MED FY24 Labor H Appropriations Health & Human Services, Dept of (HHS)   30000 0 0 2023-10-17T10:28:42-04:00
3052494 IMPACT HEALTH POLICY PARTNERS ffd61279-a611-41e3-a70a-c95ec3b3a256 Q3 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2023 third_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-10-17T10:56:50-04:00
3052500 WILLIAMS AND JENSEN, PLLC c683bf30-a62c-40dd-9ed0-116fa2baa56a Q3 WILLIAMS AND JENSEN, PLLC 41454 THE JED FOUNDATION 2023 third_quarter MED General education about mental health and suicide prevention programs. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-10-17T10:58:08-04:00
3052511 IMPACT HEALTH POLICY PARTNERS 88323c2f-e4a0-4064-a36f-d7e80b2a2ae6 Q3 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2023 third_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-10-17T11:00:05-04:00
3052526 IMPACT HEALTH POLICY PARTNERS c7dd6c27-8348-4d0f-b10d-1468dfb466cb Q3 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2023 third_quarter MED Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2023-10-17T11:03:58-04:00
3053095 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 7ab54fa3-5712-404b-86f2-65703f67e7b0 Q3 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 401106533 COALITION FOR INNOVATIVE LABORATORY TESTING, INC. 2023 third_quarter MED VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-17T12:59:37-04:00
3053115 ALPINE ADVISORS dd24d62a-ae4f-4703-bbcf-c14fd9d74400 Q3 ALPINE ADVISORS 401106595 COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION 2023 third_quarter MED Issues pertaining to government-wide federal regulation of cannabis HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-10-17T13:02:26-04:00
3053119 COMPASS MANAGEMENT PARTNERS, INC. 08efff96-a35a-48c7-87cc-2a040c022b43 Q3 COMPASS MANAGEMENT PARTNERS, INC. 401105171 THE LIVING LEGACY FOUNDATION OF MARYLAND 2023 third_quarter MED Regulations impacting accountability requirements at organ procurement organizations; organ donation matters       0 0 2023-10-17T13:03:15-04:00
3053208 TRAVERE THERAPEUTICS 48bf7db4-7129-4824-9060-760d422c1970 Q3 TRAVERE THERAPEUTICS 401104190 TRAVERE THERAPEUTICS 2023 third_quarter MED Legislation regarding FDA and clinical research, particularly with respect to rare disease and orphan drug development and the accelerated approval pathway, and related legislation regarding FY 2024 Appropriations. FY 2024 appropriations for CDC newborn screening resources. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   175000 0 0 2023-10-17T13:22:17-04:00
3053309 BROYDRICK & ASSOCIATES 3cb554b2-0287-42ba-9025-1489f86ea460 Q3 BROYDRICK & ASSOCIATES 7268 NORTHSTAR RADIOISOTOPES, LLC 2023 third_quarter MED DOE policies and cooperative agreements expansion legislation, Nuclear medicine CMS Reimbursement, NNSA reorganization. Funding for new cooperative agreements. NDAA provisions. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-10-17T13:44:56-04:00
3053429 ASSOCIATION OF AMERICAN MEDICAL COLLEGES da67e72a-3c81-46bb-8b5f-4019f12dac2b Q3 ASSOCIATION OF AMERICAN MEDICAL COLLEGES 4493 ASSOCIATION OF AMERICAN MEDICAL COLLEGES 2023 third_quarter MED Issue: Educate Congress and the administration about the impact of regulatory burden on medical research. Issue: Educate Congress and the administration about preparedness and lab safety for pathogens with pandemic potential. Issue: Support the nomination of Monica Bertagnolli to be NIH Director. Issue: Support the role of academic medical centers in engaging with ARPA-H. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,White House Office   641145 0 0 2023-10-17T14:09:43-04:00
3053543 TWENTY-FIRST CENTURY GROUP, INC. cdf5f23c-2311-4835-86b8-266692670b2b Q3 TWENTY-FIRST CENTURY GROUP, INC. 38687 NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) 2023 third_quarter MED Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD. HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2023-10-17T14:40:04-04:00
3053562 PARALYZED VETERANS OF AMERICA 18886bbe-4e01-4400-a7d2-dae84ae2fe9a Q3 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2023 third_quarter MED Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   78952 0 0 2023-10-17T14:43:29-04:00
3053803 CAPITOL COUNSEL LLC 423bc658-01aa-42ed-ba6f-15ce0326b07b Q3 CAPITOL COUNSEL LLC 313715 UNIVERSITY OF MASSACHUSETTS, BOSTON 2023 third_quarter MED Advocacy related to federal funding for UMass Boston for healthcare workforce and sustainability educational projects in FY 2024 Appropriations legislation. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-10-17T15:43:54-04:00
3054287 TWENTY-FIRST CENTURY GROUP, INC. d7808c03-c061-4ebf-9eef-a19cf651ef8c Q3 TWENTY-FIRST CENTURY GROUP, INC. 38687 GLOBAL ALZHEIMER'S PLATFORM INNOVATIONS PBC 2023 third_quarter MED Issues related to diversity in clinical trials and Alzheimers research. HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2023-10-17T17:49:06-04:00
3054736 FORBES-TATE 1a8ca6c0-21b0-4270-89d4-c2797819e3be Q3 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2023 third_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-10-17T21:12:03-04:00
3054990 WILLIAM SCHMIDT c2e298c8-bde7-4bde-bee6-99ba29f9e510 Q3 WILLIAM SCHMIDT 401107557 PULMONARY FIBROSIS FOUNDATION 2023 third_quarter MED Funding for the National Institutes of Health Funding for the Congressionally Directed Medical Research Program at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-18T07:10:29-04:00
3055070 MCCARTHY STRATEGIC SOLUTIONS 537ccd70-541d-4829-9081-67aa76af9740 Q3 MCCARTHY STRATEGIC SOLUTIONS 300936 INOTIV, INC. 2023 third_quarter MED Animal research models to biopharmaceuticals, academic and government research for realizing life saving medications HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-18T08:50:08-04:00
3055100 FORBES-TATE 16e44621-e3cb-4945-a7a9-059a71a9252c Q3 FORBES-TATE 400976792 AMGEN USA, INC. 2023 third_quarter MED Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-10-18T08:58:10-04:00
3055119 FORBES-TATE 485a3939-3a0e-4937-a70f-b9cf22cd077b Q3 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2023 third_quarter MED Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-10-18T09:02:34-04:00
3055126 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) fd40d0e3-a0c2-42ca-89c8-a80999e2e87f Q3 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2023 third_quarter MED Lobbying related to health care issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-10-18T09:03:07-04:00
3055199 FORBES-TATE a250e55b-e3c3-48fe-9bd7-63b9b645ee82 Q3 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2023 third_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-10-18T09:20:50-04:00
3055223 VENABLE LLP 23646604-a80b-4ddc-a76d-41bf9feb07d8 Q3 VENABLE LLP 39941 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2023 third_quarter MED PASTEUR Act; Reauthorization of Pandemic and all Hazards Preparedness Act; SMASH Act   40000   0 0 2023-10-18T09:30:03-04:00
3055251 FORBES-TATE 5b4247f8-f456-4c47-9b56-9cddb2c1d389 Q3 FORBES-TATE 400976792 CSL BEHRING 2023 third_quarter MED Issues related to Rx pricing. HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-10-18T09:39:00-04:00
3055462 COVINGTON & BURLING LLP c3309a85-c378-4a0d-ba44-7acdbbaedb1e Q3 COVINGTON & BURLING LLP 11195 RWE ALLIANCE INC. 2023 third_quarter MED Real-world health data and analytics policy. SENATE 100000   0 0 2023-10-18T10:18:38-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2740.964ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API